The treatment of conditions such as periodontal gum
disease cost the UK around £3 billion each year - yet there is no
simple, reliable method for real-time disease diagnosis or
monitoring its response to treatment.
In 2012, OJ-Bio, Orla Protein Technologies and Newcastle University secured £1m from the UK Technology Strategy Board's Investment in Nanoscience scheme to develop a portable, real-time, periodontal disease diagnostic device.
Like all products developed using OJ-Bio's platform, the device will detect protein markers of disease in clinical samples (in this case saliva) using disposable low-cost bio-chips housed in hand-held diagnostic devices
Diagnostic device development
An earlier study had already shown that OJ-Bio's technology could detect disease-specific indicator proteins (matrix metallo-proteases) in saliva. The £1m of new funding is for development and trial of a device for use in oral health applications.
During the clinical study the device will be used to monitor gum disease and the effects of treatment. Results will be compared with more usual forms of dental clinical testing and the study will also refine the ease with which people can use the device (dentists, but also patients themselves).
The result will be a device that could transform the way gum disease is monitored and treated - and we welcome approaches from organisations wishing to partner or licence this technology.
Meet Us at these events in 2013
Click here to find the events where you can meet us at in 2013 ...
OJ Bio Ltd has been invited to join a special group looking at the development of early warning sensor systems that can ...find out more
OJ Bio will be attending the WLSA’s 8th Annual Convergence Summit in San Diego, CA. The Convergence Summit is the premie...find out more